Randomized field trial (RTF) to demonstrate Leish-Tec® vaccine efficacy against canine visceral leishmaniasis.
A high transmission pressure and parasite challenge was assured for demonstrating vaccine efficacy.
Leish-Tec® vaccination was significant effective (71%) for prophylaxis of CVL.
Efficacy was higher among animals presenting with increased levels of anti-A2 antibodies (81%).
A tendency to reduced transmission of parasites to sand fly vectors was also observed among vaccinated animals.